Welcome to our dedicated page for Corteva news (Ticker: CTVA), a resource for investors and traders seeking the latest updates and insights on Corteva stock.
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company whose news flow reflects its focus on seed, crop protection, and digital products and services. Company announcements frequently highlight developments in agricultural technology, nature-inspired crop protection, biologicals, and strategic collaborations with partners across the agriculture, energy and biotechnology sectors.
Investors and industry followers can use this news stream to track Corteva’s progress on its stated strategy, including its planned separation into two independent public companies: a crop protection-focused business referred to as New Corteva and a seed-focused business referred to as SpinCo. News items also cover financial performance updates, such as quarterly earnings releases and guidance ranges, as well as capital allocation decisions like dividends and share repurchase programs mentioned in company communications.
Corteva’s releases often feature product and pipeline updates, including new biological and nature-inspired insect control solutions such as Goltrevo bioinsecticide and Varpelgo active, subject to regulatory approvals. They also describe joint ventures and partnerships, for example a multi-million-dollar joint venture with Hexagon Bio to accelerate nature-inspired crop protection discovery, and the Etlas joint venture with bp to develop crop-based biofuel feedstocks for sustainable aviation fuel and renewable diesel.
In addition, the company issues news about governance and leadership, including executive appointments and succession plans, as well as investor events like earnings webcasts and conference calls. This page aggregates such coverage so readers can follow Corteva’s operational updates, strategic initiatives, product announcements and financial disclosures through a single, symbol-focused news feed.
Corteva (NYSE: CTVA) reported strong full-year 2025 results with net sales $17.40B (+3% YoY) and GAAP income from continuing operations of $1.20B (+40% YoY). Operating EBITDA (non-GAAP) was $3.85B and operating EPS was $3.34. Cash from operations was $3.5B (+51%) and free cash flow was $2.9B (+69%), enabling >$1.5B returned to shareholders.
The company expects 2026 operating EBITDA of $4.0–$4.2B and operating EPS of $3.45–$3.70. A $610M cash outflow tied to the Bayer resolution is largely expected in Q1 2026; estimated incremental tariffs for 2026 are ~$80M.
Corteva (NYSE: CTVA) announced a quarterly common stock dividend of $0.18 per share, payable March 16, 2026, to shareholders of record on March 2, 2026.
The release also notes preferred stock dividends declared by EIDP, Inc., a wholly owned Corteva subsidiary, payable April 24, 2026, to record holders on April 2, 2026.
Etlas is a new 50:50 joint venture between Corteva (NYSE: CTVA) and bp (NYSE: BP) to produce crop-based oil feedstocks for sustainable aviation fuel (SAF) and renewable diesel (RD). Etlas will use canola, mustard and sunflower grown on existing cropland between main food seasons and aims to begin initial supply in 2027 for co-processing and dedicated biofuels plants. The venture targets 1 million metric tonnes of feedstock per year by the mid-2030s, which could yield over 800,000 tonnes of biofuel. Ignacio Conti will be CEO and Gaurav Sonar will chair the board. Etlas is described as a capital-light JV designed to scale feedstock supply to meet growing SAF and RD demand.
Market context: leading estimates project SAF demand rising toward ~10 million tonnes by 2030s and RD demand toward ~35 million tonnes by 2030s, positioning Etlas as a supplier option.
Corteva (NYSE: CTVA) will release its fourth quarter 2025 earnings on Tuesday, February 3, 2026 after market close via press release and the company website. A live webcast of the earnings presentation will be held on Wednesday, February 4, 2026 at 9:00 a.m. Eastern Time with an accompanying slide presentation posted on the Investor Events and Presentations page.
A replay of the webcast will be available on the Investor Events and Presentations page until February 4, 2027.
Corteva (NYSE: CTVA) and Hexagon Bio announced a multi-million-dollar joint venture on December 16, 2025 to accelerate development of nature-inspired crop protection solutions.
The JV combines Corteva’s nature-inspired crop protection franchises and bacterial natural product capabilities with Hexagon Bio’s AI-driven microbial genetics and synthetic biology discovery platform to advance pipelines across agriculture and human health. The JV was formed through Corteva Catalyst, which has partnered with 11 companies since March 2024.
Corteva (CTVA) announced two insect-management products: Goltrevo bioinsecticide, a microbial solution based on Beauveria bassiana 203, and Varpelgo active, a nature‑inspired synthetic for chewing pests.
Goltrevo targets sap‑feeding and chewing pests (whiteflies, aphids, corn leafhopper) with longer shelf life and lower resistance risk; commercial sales forecast as early as 2027 in Latin America pending approvals. Varpelgo targets chewing pests and offers a seed‑applied wireworm solution; first sales expected in early 2030s in Asia Pacific and Latin America, pending trials and regulatory review.
Corteva (NYSE: CTVA) reported strong 3Q and YTD 2025 results and raised full-year guidance on Nov 4, 2025. YTD net sales were $13.49B (up 4%) and Operating EBITDA was $3.40B. GAAP YTD income from continuing ops was $1.74B and GAAP EPS was $2.54. The company now expects 2025 net sales of $17.7B–$17.9B, Operating EBITDA $3.8B–$3.9B, and Operating EPS $3.25–$3.35; a preliminary 2026 Operating EBITDA midpoint view is $4.1B. Seed and Crop Protection showed double‑digit volume gains in new products/biologicals and margin expansion in both segments. The company reiterated separation plans for two public companies in H2 2026 and expects ~$1.0B of share repurchases in 2025.
Corteva (NYSE: CTVA) announced a common stock dividend of $0.18 per share, payable December 15, 2025 to shareholders of record on December 1, 2025. The Board authorized the dividend at its October 31, 2025 meeting.
The release also notes preferred stock dividends declared by EIDP, a wholly owned Corteva subsidiary: $1.125 per share on the $4.50 series and $0.875 per share on the $3.50 series, both payable January 23, 2026 to holders of record on January 8, 2026.
Corteva (NYSE: CTVA) announced a common stock dividend of $0.18 per share, payable December 15, 2025 to shareholders of record on December 1, 2025. The Board authorized the dividend at its October 31, 2025 meeting.
The release also notes preferred stock dividends declared by EIDP, a wholly owned Corteva subsidiary: $1.125 per share on the $4.50 series and $0.875 per share on the $3.50 series, both payable January 23, 2026 to holders of record on January 8, 2026.
Corteva (NYSE: CTVA) has scheduled its third quarter 2025 earnings release for Tuesday, November 4, 2025, after market close. The company will host a live webcast presentation on Wednesday, November 5, 2025, at 9:00 a.m. ET.
The earnings presentation will be accompanied by slides available on Corteva's Investor Events and Presentations webpage. A replay of the webcast will remain accessible on the same page until November 5, 2026.
FAQ
What is the current stock price of Corteva (CTVA)?
What is the market cap of Corteva (CTVA)?
